Chemical Compound
Prazosin Hydrochloride Imp. B (EP); Prazosin Imp. B (EP); Terazosin Hydrochloride Dihydrate Imp. M (EP); Terazosin Imp. M (EP); 1,4-Bis(furan-2-ylcarbonyl)piperazine; Prazosin Hydrochloride Impurity B; Terazosin Hydrochloride Dihydrate Impurity M; Prazosin Impurity B; Terazosin Impurity M
CAS Registry Number
31350-27-3
Primary record
Prazosin Hydrochloride Imp. B (EP); Prazosin Imp. B (EP); Terazosin Hydrochloride Dihydrate Imp. M (EP); Terazosin Imp. M (EP); 1,4-Bis(furan-2-ylcarbonyl)piperazine; Prazosin Hydrochloride Impurity B; Terazosin Hydrochloride Dihydrate Impurity M; Prazosin Impurity B; Terazosin Impurity M
- 库存
- 6,527 克
- 纯度
- 98.2 %
- CAS
- 31350-27-3
化合物标识与属性
- CAS
- 31350-27-3
- PubChem CID
- 336735
- SMILES
- C1CN(CCN1C(=O)C2=CC=CO2)C(=O)C3=CC=CO3
- Canonical SMILES
- O=C(c1ccco1)N1CCN(C(=O)c2ccco2)CC1
名称与同义词
- 31350-27-3
- 1,4-Bis(furan-2-ylcarbonyl)piperazine
- piperazine-1,4-diylbis(furan-2-ylmethanone)
- 1,4-bis(furan-2-carbonyl)piperazine
- Terazosin EP Impurity M
- CWO0S28C9J
- Prazosin EP Impurity B
- UNII-CWO0S28C9J
- 1,4-Di-2-furoyl-piperazine
- 1,4-di-2-furoylpiperazine
- RefChem:1053213
- 1,4-Di(2-furoyl)piperazine
- AC1L7K8C
- MLS003171105
- NSC-351869
- Oprea1_157686
- Oprea1_178375
- DTXSID10185276
- Piperazine, 1,4-bis(2-furanylcarbonyl)-
- MFCD00428410
- NSC351869
- 1,4-Bis-(2-furoyl)piperazine
- CHEMBL4897830
- NSC 351869
- SCHEMBL16026437
- 1,4-Di(2-furoyl)piperazine #
- CTK1C6494
- DTXCID20107767
- UPBRPYUDDNJOLW-UHFFFAOYSA-N
- C14H14N2O4
- HMS1647P07
- ZINC156403
- BBL000188
- CCG-52352
- CID336735
- EBC-54138
- SBB027401
- STK015820
- AKOS000301017
- 1,4-bis(2-furanylcarbonyl)-piperazine
- ID63852
- SB61720
- [4-(furan-2-carbonyl)piperazin-1-yl]-(furan-2-yl)methanone
- 1,4-Bis(furan-2-yl-carbonyl)piperazine
- BAS 05924437
- BB067837
- SMR001354185
- VS-00481
- 2-furyl 4-(2-furylcarbonyl)piperazinyl ketone
- Terazosin hydrochloride dihydrate impurity M
- CS-0216954
- EU-0032978
- Piperazine, 1,4-bis(2-furanylcarbonyl)- (9CI)
- ST45138413
- T7048
- C10989
- [4-(Furan-2-carbonyl)-piperazin-1-yl]-furan-2-yl-methanone
- EN300-6499035
- Prazosin EP Impurity B; Terazosin EP Impurity M
- (Piperazine-1,4-diyl)bis[(furan-2-yl)methanone]
- A899592
- SR-01000595229
- [4-(furan-2-carbonyl)piperazin-1-yl]-(2-furyl)methanone
- SR-01000595229-1
- SR-01000595229-2
- Terazosin hydrochloride dihydrate specified impurity M [EP]
- PRAZOSIN HYDROCHLORIDE IMPURITY B [EP IMPURITY]
- Q27275863
- Z32327615
- TERAZOSIN HYDROCHLORIDE DIHYDRATE IMPURITY M [EP IMPURITY]
- Prazosin BP Impurity B; Terazosin EP Impurity M; 1,1'-(1,4-Piperazinediyl)bis[1-(2-furanyl)methanone]; 1,4-Bis(furan-2-ylcarbonyl)piperazine; 1,4-Di(2-furoyl)piperazine
- Prazosin Hydrochloride Imp. B (EP); Prazosin Imp. B (EP); Terazosin Hydrochloride Dihydrate Imp. M (EP); Terazosin Imp. M (EP); 1,4-Bis(furan-2-ylcarbonyl)piperazine; Prazosin Hydrochloride Impurity B; Terazosin Hydrochloride Dihydrate Impurity M; Prazosin Impurity B; Terazosin Impurity M